The Shimadzu LCMS-9030 is a research grade mass spectrometer designed to deliver high-resolution, accurate-mass detection with incredibly fast data acquisition rates, allowing scientists to identify and quantify more compounds with greater confidence.

The company’s MEMS, or MicroElectroMechanical Systems, technology is now being used at Harvard University in the creation of microfluidic devices, which mimic the functions of living human organs, including the lung, intestine, kidney, skin, bone marrow and blood-brain barrier.

Creating access to the power and potential of mass spectrometry for more laboratories.

Lonza Pharma & Biotech to manufacture clinical batches of TxCell’s HLA-A2 CAR-Treg cellular product from its production site in Geleen (NL).

PNI and Evonik will also establish a demonstration area to showcase the NanoAssemblr suite of products in Darmstadt, Germany. This facility will be used for performing hands-on demonstrations, seminars, workshops and training programs for potential customers.

Industry-leading adapters mitigate index hopping and spread of signal in
next gen sequencing applications.

System couples the ACQUITY QDa detector with the IonSense DART ion source for rapid molecular fingerprinting of foods and food ingredients.

Bio-cannabis product pipeline ready to be commercialized In Canada.

Under a new contract, Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision.

Methods to monitor and potentially modulate the systemic response to cancer, offer new avenues for early detection, personalized medicine and therapeutic modalities.